141 related articles for article (PubMed ID: 17981520)
1. Inflammatory related changes in lung tissue mechanics after bleomycin-induced lung injury.
Pinart M; Serrano-Mollar A; Negri EM; Cabrera R; Rocco PR; Romero PV
Respir Physiol Neurobiol; 2008 Feb; 160(2):196-203. PubMed ID: 17981520
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro lung mechanics by forced oscillations: effect of bleomycin challenge.
Pinart M; Faffe DS; Romero PV
Respir Physiol Neurobiol; 2012 Apr; 181(1):46-52. PubMed ID: 22322115
[TBL] [Abstract][Full Text] [Related]
3. Single and repeated bleomycin intratracheal instillations lead to different biomechanical changes in lung tissue.
Pinart M; Serrano-Mollar A; Llatjós R; Rocco PR; Romero PV
Respir Physiol Neurobiol; 2009 Mar; 166(1):41-6. PubMed ID: 19429517
[TBL] [Abstract][Full Text] [Related]
4. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
Nici L; Santos-Moore A; Kuhn C; Calabresi P
Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
[TBL] [Abstract][Full Text] [Related]
5. Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats.
Sogut S; Ozyurt H; Armutcu F; Kart L; Iraz M; Akyol O; Ozen S; Kaplan S; Temel I; Yildirim Z
Eur J Pharmacol; 2004 Jun; 494(2-3):213-20. PubMed ID: 15212977
[TBL] [Abstract][Full Text] [Related]
6. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
[TBL] [Abstract][Full Text] [Related]
8. Exacerbation of bleomycin-induced injury and fibrosis by pneumonectomy in the residual lung of mice.
Kakizaki T; Kohno M; Watanabe M; Tajima A; Izumi Y; Miyasho T; Tasaka S; Fukunaga K; Maruyama I; Ishizaka A; Kobayashi K
J Surg Res; 2009 Jun; 154(2):336-44. PubMed ID: 19118846
[TBL] [Abstract][Full Text] [Related]
9. [Effects of curcumin on bleomycin-induced damages in pulmonary functions in rats].
Zhao CJ; Niu JZ; Wang JF; Zhou G; Tang BH
Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(12):1434-8. PubMed ID: 18837350
[TBL] [Abstract][Full Text] [Related]
10. A TSP-1 synthetic peptide inhibits bleomycin-induced lung fibrosis in mice.
Chen Y; Wang X; Weng D; Tian L; Lv L; Tao S; Chen J
Exp Toxicol Pathol; 2009 Jan; 61(1):59-65. PubMed ID: 18579356
[TBL] [Abstract][Full Text] [Related]
11. Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model.
Iyer SN; Margolin SB; Hyde DM; Giri SN
Exp Lung Res; 1998; 24(1):119-32. PubMed ID: 9457473
[TBL] [Abstract][Full Text] [Related]
12. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin.
Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F
Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102
[TBL] [Abstract][Full Text] [Related]
13. Changes in extracellular matrix and tissue viscoelasticity in bleomycin-induced lung fibrosis. Temporal aspects.
Ebihara T; Venkatesan N; Tanaka R; Ludwig MS
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1569-76. PubMed ID: 11029378
[TBL] [Abstract][Full Text] [Related]
14. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
15. Short courses of low dose dexamethasone delay bleomycin-induced lung fibrosis in rats.
Chen F; Gong L; Zhang L; Wang H; Qi X; Wu X; Xiao Y; Cai Y; Liu L; Li X; Ren J
Eur J Pharmacol; 2006 May; 536(3):287-95. PubMed ID: 16581064
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG).
Molina V; Haj-Yahia S; Solodeev I; Levy Y; Blank M; Shoenfeld Y
Autoimmunity; 2006 Dec; 39(8):711-7. PubMed ID: 17178568
[TBL] [Abstract][Full Text] [Related]
17. Collagen lysyl oxidase activity in the lung increases during bleomycin-induced lung fibrosis.
Counts DF; Evans JN; Dipetrillo TA; Sterling KM; Kelley J
J Pharmacol Exp Ther; 1981 Dec; 219(3):675-8. PubMed ID: 6170751
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of aminoguanidine on bleomycin-induced pulmonary toxicity in rat.
Chen XL; Huang SS; Li WB; Wang DH; Wang XL
Acta Pharmacol Sin; 2001 Aug; 22(8):711-5. PubMed ID: 11749843
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol alleviates bleomycin-induced lung injury in rats.
Sener G; Topaloğlu N; Sehirli AO; Ercan F; Gedik N
Pulm Pharmacol Ther; 2007; 20(6):642-9. PubMed ID: 17035056
[TBL] [Abstract][Full Text] [Related]
20. Surface and tissue forces, surfactant protein A, and the phospholipid components of pulmonary surfactant in bleomycin-induced pulmonary fibrosis in the rat.
Horiuchi T; Mason RJ; Kuroki Y; Cherniack RM
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):1006-13. PubMed ID: 1691603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
